Serum levels of HER-2 in the two groups were compared, along with a multivariate analysis of HER-2 serum levels in the patient group according with lymph nodal involvement, tumor size, local invasion, tumor staging, gender, and tobacco use (Table. The gene discussed is ERBB2; the disease is neoplasm.